Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP514508.RAVsE598mB7t52MG8uyDqhBmxaLf8AsARL31uwMaBRqos130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP514508.RAVsE598mB7t52MG8uyDqhBmxaLf8AsARL31uwMaBRqos130_assertion type Assertion NP514508.RAVsE598mB7t52MG8uyDqhBmxaLf8AsARL31uwMaBRqos130_head.
- NP514508.RAVsE598mB7t52MG8uyDqhBmxaLf8AsARL31uwMaBRqos130_assertion description "[We therefore selected this plasmid for testing in the rpe65(-/-) mouse model and observe that NP or plasmid VMD2-hRPE65-S/MAR led to structural and functional improvements in the LCA disease phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP514508.RAVsE598mB7t52MG8uyDqhBmxaLf8AsARL31uwMaBRqos130_provenance.
- NP514508.RAVsE598mB7t52MG8uyDqhBmxaLf8AsARL31uwMaBRqos130_assertion evidence source_evidence_literature NP514508.RAVsE598mB7t52MG8uyDqhBmxaLf8AsARL31uwMaBRqos130_provenance.
- NP514508.RAVsE598mB7t52MG8uyDqhBmxaLf8AsARL31uwMaBRqos130_assertion SIO_000772 23335596 NP514508.RAVsE598mB7t52MG8uyDqhBmxaLf8AsARL31uwMaBRqos130_provenance.
- NP514508.RAVsE598mB7t52MG8uyDqhBmxaLf8AsARL31uwMaBRqos130_assertion wasDerivedFrom befree-20150227 NP514508.RAVsE598mB7t52MG8uyDqhBmxaLf8AsARL31uwMaBRqos130_provenance.
- NP514508.RAVsE598mB7t52MG8uyDqhBmxaLf8AsARL31uwMaBRqos130_assertion wasGeneratedBy ECO_0000203 NP514508.RAVsE598mB7t52MG8uyDqhBmxaLf8AsARL31uwMaBRqos130_provenance.